Lunai Bioworks Inc. (LNAI) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$0.69

From 52W high−96.07%

Volume161969.00

Market cap$2.38M

P/E (TTM)—

P/S (TTM)45.7x

Div yield—

Key dataOct 19, 2026

Open

$0.69

From 52W high

−96.07%

Volume

161969.00

Market cap

$2.38M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

117.6x

P/E (TTM)

—

RSI (14)

15.8

MomentumView details →

1D Return

−30.63%

YTD Return

−92.41%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

117.6x

EV/Sales

−7172.4x

P/S (TTM)

45.7x

P/B (TTM)

−0.0x

ProfitabilityView details →

Gross Margin

−79.88%

Net Margin

−6851.97%

EBITDA Margin

−6097.91%

ROE (TTM)

0.04%

ROA (TTM)

−0.04%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+98.73%

FCF YoY

+32.83%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+98.77%

EBITDA YoY

+98.21%

MomentumView details →

1D Return

−30.63%

YTD Return

−92.41%

1Y Return

−94.47%

RSI (14)

15.8

vs 50D SMA

−72.09%

vs 200D SMA

−83.28%

Capital & dividendView details →

Debt/Equity

−0.15x

Current Ratio

0.11x

Quick Ratio

0.11x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

51992.00

Net Income (TTM)

−3.56M

Op. CF (TTM)

−5.29M

Next earningsNov 12, 2026 →

Latest newsMore news →

Lunai Bioworks announced an exclusive worldwide license and collaboration agreement with Tanaist, Inc. to add human cellular phenotyping to its Parkinson's disease discovery and validation platform.28d ago

Lunai Bioworks' BioSymetrics subsidiary shared results from a technical case study supporting the development of structure-based screening tools for chemical outputs generated by large language models and other AI systems.34d ago

Similar companies

Silo Pharma, Inc.SILO CASI Pharmaceuticals, Inc.CASI BioXcel Therapeutics, Inc.BTAI PMGC Holdings Inc.ELAB BioVie Inc.BIVIW Onconetix, Inc.ONCO Find similar companies →

Latest newsMore news →

Lunai Bioworks announced an exclusive worldwide license and collaboration agreement with Tanaist, Inc. to add human cellular phenotyping to its Parkinson's disease discovery and validation platform.28d ago Lunai Bioworks' BioSymetrics subsidiary shared results from a technical case study supporting the development of structure-based screening tools for chemical outputs generated by large language models and other AI systems.34d ago Lunai Bioworks filed a second amended complaint in its naked short selling lawsuit, adding six broker-dealers as defendants and alleging securities fraud and market manipulation under Rule 10b-5.54d ago